DNLI - Denali Therapeutics Inc.
19.7
-0.670 -3.401%
Share volume: 1,452,926
Last Updated: 03-05-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$20.37
-0.67
-0.03%
Summary score
24%
Profitability
0%
Dept financing
27%
Liquidity
50%
Performance
40%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 31-Dec-2013 - 31-Dec-2017
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-8.11%
Return on assets
-7.72%
Return on sales
0%
Return on invested capital
-109.87%
Total debt ratio
6.23%
Debt ratio change over timeo
0%
Current Ratio
23.73%
Quick Ratio
0%
Cash Position Ratio
9.49%
Short-term ratios 31-Dec-2016 - 31-Dec-2017
The data are presented for the financials results of the quarters of the last year.
Return on equity
-8.11%
Return on assets
-7.72%
Return on sales
0%
Return on invested capital
-109.87%
Total debt ratio
6.23%
Debt ratio change over timeo
0%
Current Ratio
23.73%
Quick Ratio
0%
Cash Position Ratio
9.49%
Last quarter ratios 31-Dec-2017
The data are presented for the financials results of the last quarter.
Return on equity
-4.91%
Return on assets
-4.84%
Return on sales
0%
Return on invested capital
-36.36%
Total debt ratio
4.3%
Debt ratio change over time
0%
Current Ratio
28.92%
Quick Ratio
0%
Cash Position Ratio
15.42%
Performance ratios (change over 4 years) 31-Dec-2013 - 31-Dec-2017
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | DNLI | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | -8.11% | 3.6% | 11.07% | 6.7% |
| Return on assets | -7.72% | 3.16% | 6.86% | 5.14% |
| Return on sales | 0% | 43.39% | 56.58% | 42.33% |
| Return on invested capital | -109.87% | 5.43% | 9.14% | 6.9% |
| Profitability | 0% | 54% | 100% | 71% |
| Total debt ratio | 6.23% | 61.64% | 66.49% | 46.59% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 27% | 23% | 25% | 18% |
| Current Ratio | 23.73% | 5.54% | 3.09% | 2.23% |
| Quick Ratio | 0% | 5.21% | 2.96% | 1.95% |
| Cash Position Ratio | 9.49% | 0.36% | 1.43% | 0.39% |
| Liquididy | 50% | 31% | 19% | 16% |
| Short-term ratios | DNLI | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | -8.11% | 0.73% | 4.7% | 5.28% |
| Return on assets | -7.72% | 3.16% | 5.67% | 4.87% |
| Return on sales | 0% | 44.06% | 53.59% | 39.73% |
| Return on invested capital | -109.87% | 2.07% | 5.57% | 5.5% |
| Profitability | 0% | 47% | 97% | 90% |
| Total debt ratio | 6.23% | 62.28% | 64.86% | 45.88% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 27% | 24% | 25% | 18% |
| Current Ratio | 23.73% | 5.54% | 3.09% | 2.23% |
| Quick Ratio | 0% | 5.21% | 2.96% | 1.95% |
| Cash Position Ratio | 9.49% | 0.36% | 1.43% | 0.39% |
| Liquididy | 50% | 32% | 21% | 13% |